Sonia Raheja, MD
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Raheja’s office at (408) 445-8172 to ask if they take your plan before you enroll.
California Medical Board record
Licence A131268 · Current
Licensed to practise in California · since 2014 · expires 2027-11-30 · Maharshi Dayanand University P.T. Bhagwat Dayal Sharma Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Medicaid work
$90,958 in 2024
Medicaid paid $90,958 for 808 billed services this clinician did in 2024, up to 43 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 384 | $85,640 |
| Short return visit | 353 | $3,355 |
| Psychiatric diagnostic evaluation with medical services | 22 | $1,143 |
| Short return visit (20+ min) | 49 | $820 |
| 2024 | 808 | 4 | 43 | $90,958 |
| 2023 | 1,492 | 4 | 53 | $134,397 |
| 2022 | 494 | 4 | 39 | $45,381 |
| 2021 | 257 | 3 | 38 | $3,830 |
| 2020 | 218 | 2 | 19 | $2,208 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 583 | $124,733 |
| Short return visit | 533 | $4,101 |
| Short return visit (20+ min) | 307 | $4,039 |
| Psychiatric diagnostic evaluation with medical services | 69 | $1,523 |
2022
| Clinic visit/encounter, all-inclusive | 235 | $42,055 |
| Short return visit (20+ min) | 121 | $1,442 |
| Psychiatric diagnostic evaluation with medical services | 37 | $952 |
| Short return visit | 101 | $931 |
2021
| Return visit (30+ min) | 223 | $3,046 |
| Psychiatric diagnostic evaluation with medical services | 17 | $594 |
| Telehealth originating site facility fee | 17 | $190 |
2020
| Return visit (30+ min) | 122 | $1,683 |
| Telehealth originating site facility fee | 96 | $525 |
Drugs they prescribed that Part D paid
$8,515
Pharmacies billed $8,515 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 102) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
100 generic and fewer than 11 brand-name prescriptions · $8,515 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alprazolam | 11 | $343 | $31 |
| Bupropion Xl | 13 | $149 | $11 |
| Clonazepam | 12 | $45 | $4 |
Year by year
| 2024 | 102 | 15 | 0% (0) | None | $8,515 |
| 2023 | 118 | 19 | 0% (0) | 0% | $4,353 |
| 2022 | 58 | 13 | 0% (0) | None | $9,782 |
| 2021 | 429 | 101 | 0% (0) | 7% | $56,273 |
| 2020 | 260 | 48 | 0% (0) | 14% | $90,616 |
| 2019 | 633 | 69 | 0% (0) | 11% | $147,197 |
| 2018 | 45 | 11 | 0% (0) | None | $1,570 |
| 2013 | 12 | None | 0% (0) | None | $4,448 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Dextroamphetamine-Amphetamine | 15 | $788 | $53 |
| Alprazolam | 15 | $529 | $35 |
| Lorazepam | 12 | $192 | $16 |
2022: 1 drug
| Alprazolam | 11 | $197 | $18 |
2021: 14 drugs
| Aristada | 12 | $34,819 | $2,902 |
| Bupropion Xl | 26 | $2,937 | $113 |
| Quetiapine | 36 | $1,646 | $46 |
| Duloxetine | 20 | $1,470 | $73 |
| Aripiprazole | 12 | $600 | $50 |
| Trazodone | 33 | $533 | $16 |
| Dextroamphetamine-Amphetamine | 11 | $363 | $33 |
| Escitalopram | 14 | $279 | $20 |
| Clonazepam | 22 | $234 | $11 |
| Lamotrigine | 23 | $206 | $9 |
| Lithium Carbonate Er | 14 | $200 | $14 |
| Lorazepam | 11 | $140 | $13 |
| Alprazolam | 17 | $137 | $8 |
| Zolpidem | 14 | $118 | $8 |
2020: 9 drugs
| Aristada | 28 | $78,802 | $2,814 |
| Bupropion Xl | 19 | $1,142 | $60 |
| Quetiapine | 28 | $830 | $30 |
| Escitalopram | 21 | $240 | $11 |
| Trazodone | 26 | $238 | $9 |
| Lamotrigine | 12 | $204 | $17 |
| Sertraline | 13 | $130 | $10 |
| Zolpidem | 11 | $108 | $10 |
| Alprazolam | 13 | $77 | $6 |
2019: 21 drugs
| Latuda | 29 | $46,190 | $1,593 |
| Aristada | 15 | $40,435 | $2,696 |
| Aripiprazole | 34 | $7,201 | $212 |
| Olanzapine | 58 | $1,050 | $18 |
| Quetiapine | 48 | $994 | $21 |
| Trazodone | 66 | $760 | $12 |
| Bupropion Xl | 29 | $497 | $17 |
| Divalproex | 11 | $302 | $27 |
| Paroxetine | 22 | $287 | $13 |
| Mirtazapine | 27 | $286 | $11 |
| Escitalopram | 15 | $209 | $14 |
| Sertraline | 25 | $165 | $7 |
| Lamotrigine | 17 | $138 | $8 |
| Benztropine Mesylate | 24 | $138 | $6 |
| Clonazepam | 15 | $127 | $8 |
| Lithium Carbonate | 13 | $114 | $9 |
| Risperidone | 13 | $97 | $7 |
| Zolpidem | 12 | $92 | $8 |
| Fluoxetine | 13 | $75 | $6 |
| Lorazepam | 17 | $53 | $3 |
| Citalopram Hbr | 11 | $20 | $2 |
Money from drug and device companies
$76 in 2021
| 2021 | 1 | 3 | None | $76 |
| 2020 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Vraylar | $76 | 3 payments
|
See all 3 published payments
| AbbVie | Meals · 2021-07-30 | Vraylar | $29 |
| AbbVie | Meals · 2021-07-18 | Vraylar | $21 |
| AbbVie | Meals · 2021-07-07 | Vraylar | $26 |
See earlier years (2020)
2020: $13
| Sunovion Pharmaceuticals | Latuda | $13 | 1 payment
|
Professional record
- NPI
- 1134477821
- Licence
- CA 131268, WI 72127California A131268: Current · expires 2027-11-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 1118 Meridian Ave Ste 150, San Jose, CA, 95125
- NPI first listed
- 2012-08-28
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1095 Midway Rd, Menasha, WI, 54952 · 1333 Meridian Ave, San Jose, CA, 95125 · 1642 E Capitol Expy, San Jose, CA, 95121 · 2039 Forest Ave Ste 105, San Jose, CA, 95128 · 88 E San Fernando St, San Jose, CA, 95113 · 2060 Fairmont Dr, San Leandro, CA, 94578 · 206 S Mill St, Weyauwega, WI, 54983